Key personnel

  • Clinical Pathway Chair - Natalie Doyle, nurse consultant, Living With & Beyond Cancer, The Royal Marsden NHS Foundation Trust
  • Project manager - Nicola Glover,¬†LCA

Introduction to the pathway group

The Survivorship Pathway Group was established in late 2011 with the primary aim of improving patient outcomes and experiences across the LCA. It provides the strategic direction for the development and implementation of survivorship care pathways for those for whom LCA provider trusts are their primary treatment centres. These care pathways are based on emerging national models and strategy when practicable, and build on local service developments.

A wide range of healthcare professionals and user representatives are part of the Survivorship Pathway Group, with representation not only from the 16 LCA provider Trusts, but also from third sector providers, such as The Haven.

The Survivorship Pathway Group has three affiliated Communities of Practice: for rehabilitation, complementary therapies and lymphoedema. These Communities are hubs of expertise in the field, and seek to lead and inform the development and implementation of practice in the specialties across the LCA.

The group holds regular clinical fora. These give the opportunity to engage those healthcare professionals who are providing survivorship care to LCA patients in:

  • shaping and supporting the work of the LCA Survivorship Pathway
  • sharing of good practice from across the LCA and beyond
  • education to support the implementation of LCA survivorship pathway aims and objectives
  • networking and peer support.


  • To develop and support the implementation of survivorship pathways and processes across the LCA.

  • To raise awareness of survivorship issues for people living with and beyond cancer.

  • To act as a resource across the LCA providing support, increased awareness and knowledge about survivorship issues.

  • To contribute to national and international survivorship initiatives.

  • To improve experience using the evidence within the national cancer patient experience survey.

Key documents

Close ×